
Narayana Hrudayalaya Ltd. share price
NSE: NH · Healthcare
₹1,895.30 +1.88%
Closing price data, updated 17 Nov 2026. 52-week range: -9.5% from high, +19.3% above low.
Price₹1,895.30
Market cap₹38,494 Cr
P/E44.8
P/B7.69
ROE19.7%
ROCE11.4%
Debt / equity1.29
Dividend yield0.00%
EPS₹42.28
Book value₹246.33
Operating margin15.5%
Dipscan score53 / 100
Share: WhatsAppX / TwitterTelegram
Narayana Hrudayalaya Ltd. shareholding pattern
As of Sep 2026: Promoters 63.27%, FIIs 9.01%, DIIs 10.68%, Government 0.00%, Public 16.42%.
| Holder | Sep 2026 | Jun 2026 | Mar 2026 | Dec 2025 | Sep 2025 | Jun 2025 |
|---|---|---|---|---|---|---|
| Promoters | 63.27% | 63.27% | 63.27% | 63.27% | 63.85% | 63.85% |
| FIIs | 9.01% | 9.40% | 9.98% | 11.10% | 10.49% | 10.46% |
| DIIs | 10.68% | 9.06% | 9.15% | 7.91% | 7.76% | 8.09% |
| Government | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
| Public | 16.42% | 17.65% | 16.98% | 17.10% | 17.29% | 16.98% |
| No. of Shareholders | 198,623 | 211,173 | 220,561 | 228,123 | 226,480 | 205,639 |
As filed by the company with the exchanges.
Returns
| 1 day | 1 week | 1 month | 3 months | 6 months | 1 year |
|---|---|---|---|---|---|
| +1.88% | -0.40% | +12.19% | +3.51% | +4.17% | +7.76% |
Growth
| Sales growth, 3 years | +20.5% |
| Sales growth, 5 years | – |
| Profit growth, 3 years | +9.9% |
| Profit growth, 5 years | – |
| Latest quarter sales vs last year | +73.0% |
| Latest quarter profit vs last year | +16.5% |
Strengths and weaknesses
Strengths
- Company is expected to give good quarter
- Company has a good return on equity (ROE) track record: 3 Years ROE 24.5%
Weaknesses
- Stock is trading at 7.74 times its book value
Peers in Healthcare
| Company | Price | Market cap | P/E | ROE | 1 year |
|---|---|---|---|---|---|
| Sun Pharmaceutical Industries | ₹1,867.50 | ₹4,48,076 Cr | 40.9 | 14.7% | +8.8% |
| Divi's Laboratories Ltd. | ₹11,080.00 | ₹2,94,139 Cr | 87.5 | 16.2% | +69.4% |
| Torrent Pharmaceuticals Ltd. | ₹4,691.20 | ₹1,78,438 Cr | 84.0 | 27.1% | +22.6% |
| Apollo Hospitals Enterprise Lt | ₹8,771.00 | ₹1,26,114 Cr | 56.2 | 21.9% | +16.9% |
| Laurus Labs Ltd. | ₹2,220.00 | ₹1,19,949 Cr | 89.5 | 18.2% | +125.2% |
| Zydus Lifesciences Ltd. | ₹1,192.00 | ₹1,18,902 Cr | 28.4 | 19.7% | +27.0% |
| Dr. Reddy's Laboratories Ltd. | ₹1,377.90 | ₹1,14,778 Cr | 41.0 | 12.1% | +13.7% |
| Cipla Ltd. | ₹1,394.50 | ₹1,12,658 Cr | 38.9 | 11.8% | -8.0% |
Frequently asked questions
What is the share price of Narayana Hrudayalaya Ltd.?
Narayana Hrudayalaya Ltd. (NH) last closed at ₹1,895.30 (+1.88% on the day).
What is the market cap of Narayana Hrudayalaya Ltd.?
About ₹38,494 Cr.
What is the P/E ratio of Narayana Hrudayalaya Ltd.?
The price-to-earnings ratio is 44.8, and return on equity is 19.7%.
Figures are calculated from company results and exchange prices and are for information only.